Second, we performed protein expression profiling for MEK5, ERK5, Mcm2, geminin and Ki67 on a series of PCa specimens to investigate the effects of MEK5/ERK5 signalling on origin licensing and cell cycle kinetics in vivo. The gene discussed is GMNN; the disease is posterior cortical atrophy.